Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignancy and Kidney Transplant: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Practical Guide to Address Common Myths in the Pre- and Post-kidney Transplant Management of the Elderly Patient with Cancer: An Opinion Paper.

Transplantation direct·2026
Same author

Conference Report-The Past, Current, and Future Challenges in Transplantation: A Festschrift in Honor of Professor Paul Anthony Keown.

Canadian journal of kidney health and disease·2026
Same author

Outcomes of Simultaneous Liver-Kidney Transplant and Kidney After Liver Transplant Using the Safety Net Criteria-A Single-center Experience.

Transplantation direct·2026
Same author

Corrigendum to "Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants" [American Journal of Transplantation Volume 26, Issue 1, January 2026, Pages 117-130].

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Perspectives and Practices in Pediatric to Adult Healthcare Transition in Kidney Transplantation: An American Society of Transplantation (AST) Member Survey.

Pediatric transplantation·2026
Same journal

Meta-analysis of the impact of donor hepatitis C infection on kidney transplantation outcomes.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Center-based obstacles and facilitators in the utilization of kidney paired donation in the United States, 2008-2023: A scoping review.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Defining delayed graft function in kidney transplantation: A scoping review of outcome reporting practices.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Utility of genetic testing in heart transplant recipients: a systematic review and meta-analysis.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Incretin therapy and transplant readiness: Distinguishing BMI-based access from physiologic reserve in solid organ transplantation.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

The applications of single cell RNA-seq and spatial transcriptomics in organ transplantation.

Transplantation reviews (Orlando, Fla.)·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Posttransplant anemia in solid organ recipients.

Christopher D Blosser1, Roy D Bloom

  • 1Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Transplantation Reviews (Orlando, Fla.)
|March 23, 2010
PubMed
Summary
This summary is machine-generated.

Posttransplantation anemia (PTA) is common after organ transplants and has many causes. Its impact on transplant outcomes remains unclear, necessitating further research.

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
08:04

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity

Published on: June 11, 2019

Related Experiment Videos

Last Updated: Jun 14, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
08:04

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity

Published on: June 11, 2019

Area of Science:

  • Nephrology
  • Transplantation Medicine
  • Hematology

Background:

  • Posttransplantation anemia (PTA) is a frequent complication following solid organ transplantation, particularly in kidney transplant recipients.
  • PTA is linked to increased cardiovascular risks, including morbidity and mortality.
  • Causes of PTA are multifactorial, varying between early (<6 months) and late (>6 months) posttransplant phases, and include iron deficiency, infections, inflammation, and erythropoietin deficiency.

Purpose of the Study:

  • To review the causes and potential consequences of posttransplantation anemia (PTA) in kidney transplant recipients.
  • To highlight the current knowledge gaps regarding the impact of PTA on transplant outcomes.
  • To outline current guidelines for PTA evaluation and management.

Main Methods:

  • Literature review of causes, risk factors, and management strategies for posttransplantation anemia.
  • Analysis of current clinical guidelines for anemia management in kidney transplant recipients.
  • Discussion of the limitations in current research, particularly the lack of controlled trials.

Main Results:

  • PTA has diverse etiologies, including but not limited to impaired kidney function, iron deficiency, medications, infections, rejection, inflammation, and erythropoietin deficiency.
  • The precise impact of PTA on kidney transplant outcomes, such as allograft function and patient survival, is not well-established due to limited controlled studies.
  • Current guidelines suggest evaluating hemoglobin levels below 12 g/dL and initiating treatment for levels below 11 g/dL, targeting 11-12 g/dL.

Conclusions:

  • Posttransplantation anemia is a significant issue in kidney transplant recipients with various contributing factors.
  • Further research, including controlled trials, is essential to determine if anemia correction improves outcomes.
  • Management involves addressing underlying causes, nutritional support, and potentially erythropoiesis-stimulating agents.